Gilead Sciences, Inc. (GILD): stock score 54/100

Gilead Sciences, Inc. (GILD) scores 54 out of 100 (around average among 99 US stocks) on trend, stability, fundamentals, market backdrop and news tone. Every calculation step shown. Educational, not advice.

GILD scores 54.5 out of 100 (around average), up 11.6 points from last week. Its news tone adds the most (+7.4 points: average FinBERT sentiment +0.463 over 20 articles). Its fundamentals weigh on it most (-6.8 points: revenue growth vs a year earlier: +7.4%). Our research found no proven record of these factors predicting returns.

How the score is built

Trend: 78/100 (+5.6 points)

1. Price is +13.5% vs its 100-day average → higher than 87% of the comparison group → 87
2. 12-1 month momentum +25.0% → higher than 68% of the comparison group → 68
3. Average of the two → trend score 77.8

Tested in our research: the trend rule did not hold up out of sample.

Stability: 41/100 (-1.8 points)

1. Forecast 26.4% vs normal 25.1% → ratio 1.05
2. Ratio is higher than 59% of the comparison group → 100 minus 59 → stability 40.9 (bigger expected swings than usual → lower stability)

A machine-learning volatility model beat HAR for the S&P 500 (p = 0.04); not yet tested on single stocks. This component uses HAR.

Fundamentals: 16/100 (-6.8 points)

1. Revenue growth vs a year earlier: +7.4% → higher than 43% of the comparison group → 43
2. Operating-margin change vs a year earlier: -87.2 pp → higher than 1% of the comparison group → 1
3. Change in leverage (1 - equity/assets) vs a year earlier: +11.3 pp → higher than 4% of the comparison group (lower is better) → 4
4. Average of available items → fundamentals score 15.8

Not yet tested in our research.

Market backdrop: 51/100 (+0.2 points)

1. VIX in its 5-year range: 60 after inverting (lower VIX → higher)
2. Breadth vs its 5-year range → 45
3. Credit trend vs its 5-year range → 15
4. Yield curve vs its 5-year range → 83
5. Average → backdrop score 50.8 (same for every stock)

Tested in our research: cross-asset indicators did not improve forecasts.

News tone: 87/100 (+7.4 points)

1. Average FinBERT sentiment +0.463 over 20 articles; shrunk towards 0 for few articles → tone +0.371
2. Tone vs this stock's own past year → news score 87.1

Tested in our research: news sentiment made predictions slightly worse.

GILD score history (weekly)

Health care stocks compared

• ABBV: 62/100
• AMGN: 62/100
• LLY: 60/100
• MMM: 59/100
• BIIB: 58/100
• GILD: 54/100
• PFE: 50/100
• BMY: 50/100
• UNH: 49/100
• MDT: 48/100
• MRK: 37/100
• ABT: 36/100
• JNJ: 36/100

Questions

What is Gilead Sciences, Inc.'s (GILD) Quantooo score today?

GILD scores 54 out of 100 on 2026-10-22, around average among 99 US stocks. It ranks 29th of 99 overall and 6th of 13 in Health care. It was 43 a week earlier.

What raises and lowers GILD's score?

News tone adds the most (87/100, +7.4 points) and fundamentals weighs on it most (16/100, -6.8 points). The score is 50 plus each part's weighted distance from 50.

Is GILD stock volatile right now?

Our volatility model (HAR) expects annualised swings of 26.4% over the next 20 trading days, against a normal level of 25.1% for GILD: bumpier than usual for this stock. Its stability score is 41/100 compared with the other 99 US stocks.

How are Gilead Sciences, Inc.'s fundamentals changing?

Revenue growth vs a year earlier: +7.4%; Operating-margin change vs a year earlier: -87.2 pp; Change in leverage (1 - equity/assets) vs a year earlier: +11.3 pp. Fundamentals score: 16/100. From the 10-Q filed 2026-08-06 (period to 2026-06-30).

Does the score predict GILD's share price?

No. The score describes the stock's recent data; it is not a forecast of the share price. Our own tests found no reliable ability to rank stocks by future returns, and every test, including the failures, is published. Educational, not investment advice.

Sector: Health care. Data as of 2026-10-22. Scores describe data; they are not recommendations or predictions. Educational, not investment advice.